The current management strategies for community-acquired urinary tract infection

被引：92
|
作者：
Hooton, TM [2 ]
机构：
[1] Univ Washington, Sch Med, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA
[2] Univ Washington, Harborview Med Ctr, Box 359930,325 9th Ave, Seattle, WA 98104 USA
来源：
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2003年 / 17卷 / 02期
关键词：
D O I：
10.1016/S0891-5520(03)00004-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Acute, uncomplicated urinary tract infections are among the most commonly encountered bacterial infections. Management of these infections has been made more complicated by the trend toward increasing antimicrobial resistance among uropathogens over the past few years. This article focuses on the management and follow-up of women with acute uncomplicated cystitis and pyelonephritis. In particular the appropriate role for trimethoprim-sulfamethoxazole, fluoroquinolones, and nitrofurantoin in the treatment of uncomplicated urinary tract infections is examined.
引用
收藏
页码：303 / 332
页数：30
相关论文
共 50 条
  • [21] Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain
    Barrett, SP
    Savage, MA
    Rebec, MP
    Guyot, A
    Andrews, N
    Shrimpton, SB
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (03) : 359 - 365
  • [22] Gatifloxacin in community-acquired respiratory tract infection
    Sethi, S
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (10) : 1847 - 1855
  • [23] Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections
    Gupta, K
    Hooton, TM
    Stamm, WE
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (01) : 41 - 50
  • [24] Community-acquired urinary tract infection in kidney transplantation: Risk factors for bacteremia and recurrent infection
    Wu, Sheng-Wen
    Liu, Keh-Sen
    Lin, Chih-Kuang
    Hung, Tung-Wei
    Tsai, Hui-Ching
    Chang, Horng-Rong
    Lian, Jong-Da
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2013, 112 (03) : 138 - 143
  • [25] Implication of current resistance trends on community-acquired respiratory tract infection (CA-RTI) management
    Brink, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 40 - 40
  • [26] ANTIMICROBIAL MANAGEMENT STRATEGIES FOR PATIENTS WITH COMMUNITY-ACQUIRED RESPIRATORY-TRACT INFECTIONS
    QUENZER, RU
    GUAY, DRP
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (05): : 466 - 477
  • [27] Management of community-acquired respiratory tract infections
    Remington, JS
    CLINICAL INFECTIOUS DISEASES, 2004, 39 : S141 - S141
  • [28] Pseudomonas aeruginosa in community-acquired urinary tract infection: AFORCOPIBIO 1995-1996
    Cavallo, JD
    de Mouy, D
    Fabre, R
    Garrabe, E
    Armengaud, M
    MEDECINE ET MALADIES INFECTIEUSES, 1998, 28 (03): : 258 - 259
  • [29] Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin
    Henry, D
    Ellison, W
    Sullivan, J
    Mansfield, DL
    Magner, DJ
    Dorr, MB
    Talbot, GH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2262 - 2266
  • [30] Susceptibility of Escherichia coli strains in children with community-acquired urinary tract infection in Tessin
    Borsari, A. G.
    Bucher, B.
    Brazzola, P.
    Simonetti, G. D.
    Dolina, M.
    Bianchetti, M. G.
    SWISS MEDICAL WEEKLY, 2009, 139 (21-22) : 2S - 2S
12345